Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas-Reference-Cited by-同舟云学术

Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas

Published:1998-10-07 Issue:19 Volume:90 Page:1473-1479
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Cairncross J. Gregory,Ueki Keisuke,Zlatescu Magdelena C.,Lisle David K.,Finkelstein Dianne M.,Hammond Robert R.,Silver Jonathan S.,Stark Paul C.,Macdonald David R.,Ino Yasushi,Ramsay David A.,Louis David N.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/90/19/1473/18048499/90-19-1473.pdf

Reference33 articles.

1. Successful chemotherapy for recurrent malignant oligodendroglioma;Cairncross;Ann Neurol,1988

2. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma;Macdonald;Ann Neurol,1990

3. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.;Cairncross;J Clin Oncol,1994

4. The treatment of oligodendrogliomas and mixed oligodendroglioma- astrocytomas with PCV chemotherapy;Glass;J Neurosurg,1992

5. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas;Kim;J Neurosurg,1996

Cited by 1367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of CNS WHO grade 2 oligodendroglioma in adult patients: a single-institution experience;Discover Oncology;2024-07-06

2. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy;Brain Tumor Pathology;2024-04

3. Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid;Cancers;2024-02-29

4. A benchmarking framework for the accurate and cost-effective detection of clinically-relevant structural variants for cancer target identification and diagnosis;Journal of Translational Medicine;2024-01-16

5. SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway;International Journal of Biological Sciences;2024